COPENHAGEN, Denmark, January 31 /PRNewswire-FirstCall/ -- Genmab A/S
(OMX: GEN) announces its financial calendar for 2008 as follows:
Publication of the Annual Report for 2007 Monday, March 31, 2008
Annual General Meeting 2008 Wednesday, April 23, 2008
Publication of the Interim Report for the Wednesday, May 28, 2008
first quarter 2008
Publication of the Interim Report for the Wednesday, August 27, 2008
first half 2008
Publication of the Interim Report for the Wednesday, October 29, 2008
first nine months 2008
Publication of the financial reports will be after market close on the date of the event.
About Genmab A/S
Genmab is a leading international biotechnology company focused on developing fully human antibody therapeutics for unmet medical needs. Using unique, cutting-edge antibody technology, Genmab's world class discovery and development teams have created and developed an extensive pipeline of products for potential treatment of a variety of diseases including cancer and autoimmune disorders. As Genmab advances towards a commercial future, we remain committed to our primary goal of improving the lives of patients who are in urgent need of new treatment options. For more information on Genmab's products and technology, visit http://www.genmab.com.
This press release contains forward looking statements. The words
"believe", "expect", "anticipate", "intend" and "plan" and similar
expressions identify forward looking statements. Actual results or
performance may differ materially from any future results or performance
expressed or implied by such statements. The important factors that could
cause our actual results or performance to differ materially include, among
others, risks associated with product discovery and development
|SOURCE Genmab A/S|
Copyright©2008 PR Newswire.
All rights reserved